|
|
 |
|
ONCOLOGY EXCHANGE
offers a unique forum for expert exchange of current and emerging
trends in diagnosis, treatment and supportive cancer care in Canada.
It provides interdisciplinary Canadian cancer healthcare professionals
with an exceptional venue for contributing original articles that
communicate the benefit of their knowledge and experience.
ONCOLOGY EXCHANGE
is published 4 times per year. It is circulated to 4,600 oncology
professionals, including medical oncologists, radiation oncologists,
uro-oncologists, psycho-oncologists, palliative care specialists
and oncology nurses.
We welcome letters, scientific articles, reviews
and topics for debate about oncology clinical practice from Canadian
experts. Authors of feature articles receive an honorarium. The
journal follows the International Committee of Medical Journal Editors
Uniform Requirements for Manuscripts Submitted to Biomedical Journals,
available at www.ICMJE.org.
The following outlines requirements for submissions to Oncology
Exchange.
General Criteria
- The article must be original; that is, has
not been published elsewhere in the same form.
- Canadian authors are given preference.
- Feature articles can run up to 2000 words,
with longer or shorter articles considered.
- Departments and columns can run up to 1500
words, depending on the section.
- Primary research articles should conform to
conventional standards for evidence and value.
- Please address correspondence to the attention
of Emily Andrews, Managing Editor,
by Email: editors@oncologyex.com;
by Fax: (514) 397-0228
|
|
Editorial Procedure
|
| Review
of Submissions |
Authors
are encouraged to provide a brief outline of the proposed article
in advance of submission. Acceptance of an article for publication
is subject to scrutiny by the Editorial Advisory Board. All content
is reviewed and approved by the Medical Editor in Chief, Dr. Jean
Maroun. Articles specific to psycho-oncology and healthcare policy
are reviewed and approved under the direction of the Co-Editor in
Chief, Dr. Barry Bultz. Each article is also reviewed by at least
one other reviewer, often a member of the Editorial Advisory Board
or Expert panel.
|
| Additional
Criteria |
Submissions in all categories (see below) should:
- Be relevant to the practice of Canadian oncology professionals
- Contain accurate and valid information
- Present the information clearly and logically
|
| Format |
Use plain text formatting only, as any other formatting
will be stripped in page proofs. Please include an abstract of 100-200
words. All references must be provided, as necessary, in standard
biomedical style. Relevant illustrative material should be submitted
with the article, including tables, charts, treatment algorithms,
diagnostic visuals or photographs. Submissions should be sent preferably
by Email as an attachment in Microsoft Word. Faxed or couriered
submissions are also accepted. An honorarium will be provided for
accepted submissions upon publication.
|
| Manuscript
Process |
All editing, copyediting, proofreading, and
layouts are the responsibility of Parkhurst.
- The Managing Editor of ONCOLOGY EXCHANGE is assigned
to edit and/or copyedit all submissions accepted for publication
to conform to the standards set for the Journal.
- After the article has been edited/copyedited, it will be returned
to the author(s) for verification and approval.
- The article will then be reviewed and approved by the Editors
in Chief and other members of the Advisory Board or Expert Panel.
Any queries, suggested changes or corrections that the Editor
in Chief makes will be submitted to the author(s) for review.
- Once the manuscript is deemed final (i.e. has been approved
by the authors and the Editors), the layout stage follows, with
all graphic treatment produced by Parkhurst.
- Page proofs will be sent to authors FYI by email (as PDF files)
or fax.
PLEASE NOTE:
The Editors of ONCOLOGY EXCHANGE reserve the right
to postpone publication of an accepted submission for space considerations.
|
| Copyright |
The
copyright is transferred to Parkhurst when the article is accepted
for publication. The copyright covers the exclusive rights to reproduce
and distribute the article in any form. A pdf of the article may appear
on the journal's open-access website, www.oncologyex.com.
|
| Categories |
| Scientific
/ Clinical |
DISCOURSE: Emerging
trends and recommendations
Description: Qualitative evidence-based
research, review and/or and survey articles on topics that address
primary diagnostic or treatment modalities, present and future.
Topics: All areas of oncologic research interest in the more
common cancers (e.g. breast, prostate, lung, bladder, cervical,
ovarian): diagnostic imaging, blood work and genetic testing, treatment
with surgery, radiation or chemotherapy, adjuvant therapy, pain
management, nutrition etc. Articles can also address reviews of
research within a specific drug class, evaluation of pros and cons,
patient selection, assessment of recommendations for treatment with
a drug class, procedure or device.
Length: Up to 3,000 words including tables and references.
|
| |
PROTOCOLS & PRACTICES:
Perspectives on cancer management
Description: Clinical reports
on advances and innovations in the diagnostics, treatment and collaborative
care of cancer.
Topics: These can address any area in oncology, but can also
include discussions or critiques of guidelines. Also, more patient-centred
issues, such as pain management, palliation and social support,
can also be included. Differing from the research section above,
authors are able to report their clinical experiences with therapeutics,
new diagnostic methods or devices, etc.
Length: Up to a maximum of 3,000
words including tables and references.
|
| |
CONTINUING CARE:
Courses & directions
Description: Review articles that
allow authors to take a critical look at issues and strategies in
psycho-oncology, social support, rehabilitation, integrated services
and other factors that affect both patients and their healthcare
teams.
Topics: Medical decision-making;
evaluation of the implementation of treatment guidelines in specific
centres (if not already addressed in PROTOCOLS & PRACTICES),
reports on interdisciplinary care (what works, what doesn't, what's
missing), etc.
Length: Up to a maximum of 3,000
words including tables and references.
|
| |
ORIGINAL RESEARCH:
Canadian clinical investigations
Description:
Reports of original clinical research that address primary diagnostic
or treatment modalities, present and future.
Topics:
All areas of clinical oncologic research: diagnostic imaging, blood
work and genetic testing, treatment with surgery, radiation or chemotherapy,
adjuvant therapy, pain management, nutrition etc; may include less
common cancer types and disease sites.
Length:
Up to 3,000 words including tables and references, including an abstract
of up to about 400 words.
|
| |
LANDMARKS: Latest
research profiles
Description: Brief summary of
a recently presented clinical trial (either at a major conference
or in the literature) with a commentary by a leading Canadian expert,
addressing clinical implications and next steps in research.
Length: Summary 200-300 words
(usually supplied by Parkhurst); Commentary 600-800 words, references
are optional.
|
| |
CROSSROADS: Profiles in
innovative care
Description: Highlights
initiatives in patient care programs
Length: 1200-1800
words. |
| |
BIOSTATISTICS: Numbers
& methodologies
Description: Scientific articles
that elucidate the role of statistical analyses of clinical trial
design, outcomes data, etc.
Length: Up to a maximum of 2,000
words including tables and references.
|
| Health Policy & Politics |
STATUS REPORT: Clinical
practice & Cancer Health Policy
Description: This can take the
form of a review, update, commentary or position paper on currents
in the political discourse of Canadian cancer care.
Topics: Provincial and/or federal
policy initiatives, reflections on cost-benefit analyses, access
to care and drug funding issues, ethical concerns, etc.
Length: Up to 3,000 words including
references.
|
| Continuing Professional
Education |
TOOLS OF THE TRADE:
Professional & Patient Resources
Description: An overview, assessment
or review of new and/or updated tools for oncology professionals
and their patients.
Topics: teaching aids (e.g. books,
software, CD ROMs), clinical programs, updates on maintenance of
certification, etc.
Length: Up to 1500 words.
CORE CURRICULUM:
Reports from Canadian meetings
Description: May be a general
report or highlight specific aspects of the meeting.
Length: Up to 2000 words.
|
|
Other Topics
|
Topics in areas not addressed in these above
categories may be considered:
- We accept survey or discussion articles
from authors that reflect clinical experience or argue the evidence
for efficacy and/or cost-effectiveness (e.g.) of a particular
intervention or therapeutic strategy.
- Supportive care articles related to psycho-oncology,
nursing, palliative care, pain management etc.
|
| |
|
| |
|
